Multidrug resistance means that bacteria or viruses are insensitive towards various antibiotics or antivirals, respectively.
Synonyms
Multiple drug resistance
Detailed description
There is a general increase of resistances against antibiotics. Infections with multidrug-resistant pathogens pose a serious problem as their treatment with antibiotics is difficult or not possible any more.
Enterobacteria such as Escherichia coli or Klebsiella pneumoniae are dreaded hospital germs that can cause serious intestinal and urinary tract infections. The risk of infection with these pathogens
Multidrug-resistant bacteria are spreading worldwide, and new antibiotics and strategies against deadly infectious diseases are urgently needed. With INCATE (INCubator for Antibacterial Therapies in
To advance anti-tuberculosis (TB) science and enable the progression of new, safe, and affordable treatment solutions for TB patients worldwide, a new consortium of 30 partners from 13 countries has
The successful treatment of multidrug-resistant tuberculosis requires clarification in advance as to which antibiotics the pathogens are resistant to. Classic testing in the laboratory is very time
The human immune system can effectively prevent and control viral infections. While many viruses can be neutralized and eliminated from the human body, other viruses persist after infection. However, they are often controlled throughout the entire human lifespan (e.g. certain herpes viruses like CMV ...
Scientists at the Research Center Borstel and the German Center for Infection Research (DZIF) identified a multidrug resistant Tuberculosis-strain in Southern Africa, that is not detected by modern
Implementation of evidence-based infection control practices to reduce healthcare-associated infection remains a national and international priority. R-Net investigates the effect of various interventions aimed at limiting the spread of infections due to multi-drug resistant organisms (MDRO) ...
Healthcare-associated infections have been growing continuously for years, resulting in hundreds of thousands of avoidable deaths each year. The main culprit is bacteria that have become resistant to
Since 2014, DZIF scientists are developing a promising antibiotic for tuberculosis, which has also proven to be effective effective against multidrug-resistant pathogens in preclinical tests. The new
An international team managed by scientists at the Research Center Borstel and the German Center for Infection Research (DZIF) have examined a new method for detecting resistant tuberculosis strains